Literature DB >> 22196490

Phenotypic variability in a portuguese family with x-linked creatine transport deficiency.

Paula Garcia1, Fidjy Rodrigues, Carla Valongo, Gajja S Salomons, Luísa Diogo.   

Abstract

Cerebral creatine transporter deficiency, attributable to mutations in the SLC6A8 gene, causes X-linked mental retardation, language delay, epilepsy, and autistic features. In contrast with creatine synthesis defects, the vast majority of patients with SLC6A8 deficiency do not respond to treatment. We describe a Portuguese family with a mutation (c.456C>T; p.Gln486X) in the SL6CA8 gene: two adult monozygotic twin brothers, with psychomotor delay and severe speech impairment. The family also includes their maternal half-sister with psychomotor retardation, predominantly in language, and their mentally retarded mother. This family illustrates the remarkable phenotypic variability in this condition. Investigation of creatine metabolism is mandatory in patients with developmental delay of unknown etiology, to detect this condition.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22196490     DOI: 10.1016/j.pediatrneurol.2011.10.005

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  2 in total

1.  Treatment outcome of creatine transporter deficiency: international retrospective cohort study.

Authors:  Theodora U J Bruun; Sarah Sidky; Anabela O Bandeira; Francoise-Guillaume Debray; Can Ficicioglu; Jennifer Goldstein; Kairit Joost; Dwight D Koeberl; Diogo Luísa; Marie-Cecile Nassogne; Siobhan O'Sullivan; Katrin Õunap; Andreas Schulze; Lionel van Maldergem; Gajja S Salomons; Saadet Mercimek-Andrews
Journal:  Metab Brain Dis       Date:  2018-02-12       Impact factor: 3.584

2.  A novel SLC6A8 mutation associated with intellectual disabilities in a Chinese family exhibiting creatine transporter deficiency: case report.

Authors:  Qin Wang; Jingxin Yang; Yang Liu; Xingping Li; Fuwei Luo; Jiansheng Xie
Journal:  BMC Med Genet       Date:  2018-11-06       Impact factor: 2.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.